Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData’s new report, “Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the United States Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the four market categories.
• Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices market.
• Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc. and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the United States Drug Delivery Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Contents

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 DRUG DELIVERY DEVICES IN UNITED STATES

3.1 Drug Delivery Devices, Market Segmentation
3.2 Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010
3.4 Drug Delivery Devices Market, United States, Category Contribution (%), 2010
3.5 Drug Delivery Devices, United States, Category Volume (Units), 2003-2017
3.6 Drug Delivery Devices, United States, Company Share (2009-2010)

4 CENTRAL VENOUS CATHETERS IN UNITED STATES

4.1 Central Venous Catheters, Market Segmentation
4.2 Central Venous Catheters Market, United States, Revenue Mix ($m), 2010
4.3 Central Venous Catheters Market, United States, Segment Contribution (%), 2010
4.4 Central Venous Catheters Overall Revenue (2003-2017)
4.5 Central Venous Catheters Overall Volume (2003-2017)
4.6 Central Venous Catheters Average Price (2003-2017)
4.7 Central Venous Catheters Distribution Share (2009-2010)
4.8 Central Venous Catheters, United States, Company Share (2009-2010)

5 INFUSION SYSTEMS IN UNITED STATES

5.1 Infusion Systems, Market Segmentation
5.2 Infusion Systems Market, United States, Revenue Mix ($m), 2010
5.3 Infusion Systems Market, United States, Segment Contribution (%), 2010
5.4 Infusion Systems Overall Revenue (2003-2017)
  5.4.1 Syringe Pumps Revenue (2003-2010)
  5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010)
5.5 Infusion Systems Overall Volume (2003-2017)
  5.5.1 Syringe Pumps Volume (2003-2010)
  5.5.2 Ambulatory Infusion Pumps Volume (2003-2010)
5.6 Infusion Systems Average Price (2003-2017)
5.7 Infusion Systems Distribution Share (2009-2010)
5.8 Infusion Systems, United States, Company Share (2009-2010)

6 METERED DOSE INHALER DEVICES IN UNITED STATES

6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
6.5 Metered Dose Inhaler Devices, United States, Company Share (2009-2010)

7 NEEDLE FREE INJECTIONS IN UNITED STATES

7.1 Needle Free Injections Overall Revenue (2003-2017)
7.2 Needle Free Injections Overall Volume (2003-2017)
7.3 Needle Free Injections Average Price (2003-2017)
7.4 Needle Free Injections Distribution Share (2009-2010)
7.5 Needle Free Injections, United States, Company Share (2009-2010)

8 OVERVIEW OF KEY COMPANIES IN UNITED STATES DRUG DELIVERY DEVICES MARKET

8.1 GlaxoSmithKline plc
  8.1.1 Company Overview
  8.1.2 Share in the United States Drug Delivery Devices Market
8.2 Hospira, Inc.
  8.2.1 Company Overview
  8.2.2 Share in the United States Drug Delivery Devices Market
8.3 CareFusion Corporation
  8.3.1 Company Overview
  8.3.2 Share in the United States Drug Delivery Devices Market
8.4 Boehringer Ingelheim GmbH
  8.4.1 Company Overview
  8.4.2 Share in the United States Drug Delivery Devices Market
8.5 AstraZeneca PLC
  8.5.1 Company Overview
  8.5.2 Share in the United States Drug Delivery Devices Market
8.6 Baxter International Inc.
  8.6.1 Company Overview
  8.6.2 Share in the United States Drug Delivery Devices Market
8.7 Medtronic, Inc.
  8.7.1 Company Overview
8.8 Teleflex Incorporated
  8.8.1 Company Overview
8.9 Smiths Medical
  8.9.1 Company Overview
8.10 Fresenius Kabi AG
  8.10.1 Company Overview
8.11 B. Braun Melsungen AG
  8.11.1 Company Overview
8.12 Terumo Corporation
  8.12.1 Company Overview
8.13 Consort Medical plc
  8.13.1 Company Overview
8.14 3M Health Care
  8.14.1 Company Overview
8.15 Edwards Lifesciences Corporation
  8.15.1 Company Overview
8.16 Becton, Dickinson and Company
  8.16.1 Company Overview
8.17 Cook Medical Incorporated
  8.17.1 Company Overview
8.18 INJEX - Equidyne Systems
  8.18.1 Company Overview
8.19 Antares Pharma, Inc.
  8.19.1 Company Overview
8.20 Bioject Medical Technologies Inc.
  8.20.1 Company Overview

9 DRUG DELIVERY DEVICES MARKET PIPELINE PRODUCTS

10 FINANCIAL DEALS LANDSCAPE

10.1 Acquisition
  10.1.1 CarePoint Partners Acquires Premier Infusion
  10.1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals
  10.1.3 BTG International To Acquire Biocompatibles
  10.1.4 Nordson Completes Acquisition Of Micromedics
  10.1.5 Cardinal Health Sells 13.7% Stake In Carefusion
  10.1.6 Cellectis Acquires Cyto Pulse Sciences
10.2 Partnerships
  10.2.1 Eli Lilly Enters Into Collaboration With Medtronic
  10.2.2 West Pharmaceutical Enters Into Agreement With CareFusion
  10.2.3 Nile Therapeutics Enters Into An Agreement With Medtronic
  10.2.4 Hospira Enters Into An Agreement With Smiths Medical
  10.2.5 AorTech International Enters Into Technology License Agreement

11 RECENT DEVELOPMENTS

11.1 Strategy and Business Planning
  11.1.1 Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products
  11.1.2 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units
  11.1.3 Aug 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago
  11.1.4 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey
  11.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring
  11.1.6 Jul 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha
  11.1.7 Jul 01, 2010: Shionogi Announces Reorganization Of US Operations
  11.1.8 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany
11.2 Legal and Regulatory
  11.2.1 Mar 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information
  11.2.2 Feb 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical
  11.2.3 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter
  11.2.4 Nov 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases
  11.2.5 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions
  11.2.6 Sep 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger
  11.2.7 Jul 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit
  11.2.8 Jul 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing
  11.2.9 Jun 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical
11.3 Government and Public Interest
  11.3.1 Mar 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment
  11.3.2 Feb 17, 2011: Delcath Achieves ISO 13485 Certification
  11.3.3 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design
  11.3.4 Oct 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention
  11.3.5 Aug 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch
  11.3.6 Aug 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger
  11.3.7 Jun 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA
11.4 Product News
  11.4.1 Jul 27, 2010: Dentistry Today Selects Milestone’s STA Single Tooth Anesthesia System For Top 100 Products Award Program
  11.4.2 Jul 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US
  11.4.3 Jul 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine

12 APPENDIX

12.1 Definitions of Markets Covered in the Report
  12.1.1 Drug Delivery Devices
12.2 Research Methodology
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panels
12.8 GlobalData Consulting
12.9 Currency Conversion
12.10 Contact Us
12.11 Disclaimer 141

LIST OF TABLES

Table 1: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices Market, United States, Category Contribution (%), 2010
Table 3: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017
Table 4: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010
Table 5: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017
Table 6: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017
Table 7: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010
Table 8: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017
Table 9: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2009-2010
Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2010
Table 11: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 12: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 13: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 14: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 15: Central Venous Catheters, United States, Average Price ($), Historic, 2003-2010
Table 16: Central Venous Catheters, United States, Average Price ($), Forecast, 2010-2017
Table 17: Central Venous Catheters, United States, Distribution Share by Revenue ($m), 2009-2010
Table 18: Central Venous Catheters, United States, Company Share by Revenue ($m), 2009-2010
Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2010
Table 20: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 21: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 22: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 23: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 24: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 25: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 26: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 27: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 28: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 29: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 30: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 31: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 32: Infusion Systems, United States, Average Price ($), Historic, 2003-2010
Table 33: Infusion Systems, United States, Average Price ($), Forecast, 2010-2017
Table 34: Infusion Systems, United States, Distribution Share by Revenue ($m), 2009-2010
Table 35: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2010
Table 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010
Table 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017
Table 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010
Table 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017
Table 40: Metered Dose Inhaler Devices, United States, Average Price ($), Historic, 2003-2010
Table 41: Metered Dose Inhaler Devices, United States, Average Price ($), Forecast, 2010-2017
Table 42: Metered Dose Inhaler Devices, United States, Distribution Share by Revenue ($m), 2009-2010
Table 43: Metered Dose Inhaler Devices, United States, Company Share by Revenue ($m), 2009-2010
Table 44: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010
Table 45: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017
Table 46: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010
Table 47: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017
Table 48: Needle Free Injections, United States, Average Price ($), Historic, 2003-2010
Table 49: Needle Free Injections, United States, Average Price ($), Forecast, 2010-2017
Table 50: Needle Free Injections, United States, Distribution Share by Revenue ($m), 2009-2010
Table 51: Needle Free Injections, United States, Company Share by Revenue ($m), 2009-2010
Table 52: Drug Delivery Devices Market Pipeline Products
Table 53: CarePoint Partners Acquires Premier Infusion
Table 54: SurModics Plans The Sale Of SurModics Pharmaceuticals
Table 55: BTG International To Acquire Biocompatibles
Table 56: Nordson Completes Acquisition Of Micromedics
Table 57: Cardinal Health Sells 13.7% Stake In Carefusion
Table 58: Cellectis Acquires Cyto Pulse Sciences
Table 59: Eli Lilly Enters Into Collaboration With Medtronic
Table 60: West Pharmaceutical Enters Into Agreement With CareFusion
Table 61: Nile Therapeutics Enters Into An Agreement With Medtronic
Table 62: Hospira Enters Into An Agreement With Smiths Medical
Table 63: AorTech International Enters Into Technology License Agreement
Table 64: USD to Local Currency, United States, Average Actual Rate 2003-2010 141

LIST OF FIGURES

Figure 1: Drug Delivery Devices, Market Segmentation
Figure 2: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017
Figure 3: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010
Figure 4: Drug Delivery Devices Market, United States, Category Contribution (%), 2010
Figure 5: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017
Figure 6: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010
Figure 7: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017
Figure 8: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017
Figure 9: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010
Figure 10: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017
Figure 11: Drug Delivery Devices, United States, Company Share (%), 2010
Figure 12: Central Venous Catheters, Market Segmentation
Figure 13: Central Venous Catheters Market, United States, Revenue Mix ($m), 2010
Figure 14: Central Venous Catheters Market, United States, Segment Contribution (%), 2010
Figure 15: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 16: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 17: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 18: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 19: Central Venous Catheters, United States, Company Share (%), 2010
Figure 20: Infusion Systems, Market Segmentation
Figure 21: Infusion Systems Market, United States, Revenue Mix ($m), 2010
Figure 22: Infusion Systems Market, United States, Segment Contribution (%), 2010
Figure 23: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 24: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 25: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 26: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 27: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 28: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 31: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 32: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 33: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 34: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 35: Infusion Systems, United States, Company Share (%), 2010
Figure 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010
Figure 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017
Figure 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010
Figure 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017
Figure 40: Metered Dose Inhaler Devices, United States, Company Share (%), 2010
Figure 41: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010
Figure 42: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017
Figure 43: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010
Figure 44: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017
Figure 45: Needle Free Injections, United States, Company Share (%), 2010
Figure 46: GlaxoSmithKline plc, Company Share (%),United States Drug Delivery Devices Market, 2010
Figure 47: Hospira, Inc., Company Share (%),United States Drug Delivery Devices Market, 2010
Figure 48: CareFusion Corporation, Company Share (%),United States Drug Delivery Devices Market, 2010
Figure 49: Boehringer Ingelheim GmbH, Company Share (%),United States Drug Delivery Devices Market, 2010
Figure 50: AstraZeneca PLC, Company Share (%),United States Drug Delivery Devices Market, 2010
Figure 51: Baxter International Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 95

COMPANIES MENTIONED

GlaxoSmithKline plc
Hospira, Inc.
CareFusion Corporation
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
Medtronic, Inc.
Teleflex Incorporated
Smiths Medical
Fresenius Kabi AG
B. Braun Melsungen AG
Terumo Corporation
Consort Medical plc
3M Health Care
Edwards Lifesciences Corporation
Becton, Dickinson and Company
Cook Medical Incorporated
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc. Skip to top